The field of the invention is use of energetic low-molecular weight gas mixtures, and especially syngas and/or methane as feedstock for microbial production of fuel components, particularly alcohols, aldehydes, and/or acids.
Microbial production of various biofuel components is well known in the art and may use isolated naturally occurring microorganisms, or genetically engineered microorganisms that have one or more genes added or modified/deleted to improve product yield.
For example, GB2018822B teaches use of methylotrophic bacteria to produce various hydrocarbon products from methane as feedstock. While such methods advantageously allow use of aerobic culture conditions, yields are often less than desirable and the culture medium typically requires the presence of one or more methyl-radical donating carbon-containing compounds.
In other examples, anaerobic bacteria have been used to convert carbon monoxide to alcohols, including butanol, ethanol, and acetic acid, and typical microorganisms include those of the genus Clostridium (e.g., Clostridium lungdahlii, including those described in WO 00/68407, EP 117309, U.S. Pat. Nos. 5,173,429, 5,593,886, and 6,368,819, WO 98/00558 and WO 02/08438, and Clostridium autoethanogenum (Aribini et al, Archives of Microbiology 161: pp 345-351)). Other Clostridial species using syngas are described in US 2010/0203606 and 2007/0275447 for production of ethanol from carbon monoxide. Futher suitable bacteria include those of the genus Moorella, including Moorella sp HUC22-1, (Sakai et al, Biotechnology Letters 29: pp 1607-1612), and those of the genus Carboxydothermus (Svetlichny, V. A., Sokolova, T. G. et al (1991), Systematic and Applied Microbiology 14: 254-260). However, the media composition in many cases is relatively complex, and culture conditions are often difficult to reproduce.
To reduce complexity for media, carbon dioxide may be added to the medium while maintaining free acid concentration below a threshold value to so improve production flow as previously shown in WO2009/114127 where selected (typically Clostridial) microorganisms produce ethanol using syngas as a feedstock. However, anaerobic culture conditions must be maintained during the fermentation in most cases, which will once more increase operational complexity. Further media modifications are described in US 2011/0236919 in which a surface tension active compound is used to control quantities of the dissolved gases.
Likewise, WO 2011/139804 describes various hybrid production processes in which oxyhydrogen microorganisms (and in particular purple non-sulfur photosynthetic bacteria) are employed for non-photosynthetic carbon capture and conversion of inorganic and/or C1 carbon sources into useful organic compounds. However, the production set-up for biofuel components in this process is yet again relatively complex.
Thus, there is still a need to provide improved systems and methods for production of biofuel components, and particularly alcohols, aldehydes, and acids using microorganisms in a conceptually simple and effective manner using low-molecular weight gases and mixtures thereof.
The inventive subject matter is directed to cells, methods, and culture conditions for microbial strains and genetically modified microbial strains to generate from low-molecular weight gases in a conceptually simple manner various biofuel components, and particularly short- and mid-chain alcohols, aldehydes, and carboxylic acids.
In one aspect of the inventive subject matter, a method of producing a value product that includes a step of providing syngas or methane, and using a microorganism to convert the syngas or methane into reduction equivalents and at least one of CO2 and formaldehyde, and a further step of using a CBB cycle, a serine cycle, or a RuMP cycle in the microorganism to produce the value product.
In some aspects of the inventive subject matter, the microorganism is genetically modified to convert CO from syngas into CO2 and to generate the reduction equivalents during the conversion of the CO to CO2. For example, the genetic modification may include a recombinant gene that encodes an enzyme having CO reductase activity, and optionally a recombinant gene that encodes an enzyme having hydrogenase activity. In other aspects, the microorganism is genetically modified to convert methane into formaldehyde and to generate the reduction equivalents during the conversion of the methane to the formaldehyde. For example, such genetic modification may include one or more recombinant genes that encode an enzyme having an activity selected from the group consisting of methane monooxygenase, alcohol dehydrogenase, and formaldehyde dismutase. In still further aspects, the microorganism may also be genetically modified to convert methane into CO2 and to generate the reduction equivalents during the conversion of the methane to the formaldehyde. For example, such genetic modifications may include at least one recombinant gene that encodes an enzyme having an activity selected from the group consisting of factor F420-reducing hydrogenase, F420-dependent methylene-H4SPT dehydrogenase, heterodisulfide reductase, methyl-coenzyme M reductase, methyl-H4MPT:coenzyme M methyltransferase complex, F420-dependent methylene-H4SPT reductase, 5,6,7,8-tetrahydromethanopterin hydro-lyase (formaldehyde-activating enzyme), and formaldehyde dehydrogenase.
In still further contemplated aspects, the microorganism may also be genetically modified to have at least one recombinant gene in the CBB cycle, the serine cycle, or the RuMP cycle. For example, the recombinant gene in the CBB cycle encodes a protein having phosphoribulokinase activity or phosphoketolase activity. Additionally, it is contemplated that the microorganism may be genetically modified to have reduced or abrogated activity for at least one of aldehyde dehydrogenase and alcohol dehydrogenase. Thus, especially preferred value products include aldehydes (e.g., butyraldehyde).
While not limiting to the inventive subject matter, the microorganism may be an aerobic microorganism (e.g., belonging to the genus of Ralstonia), that is cultivated under aerobic conditions. Alternatively, the microorganism may also be an aerobic microorganism that is genetically modified to grow under anaerobic conditions.
Therefore, the inventor also contemplates a genetically engineered microorganism that comprises a plurality of genes to provide enzymatic functions for (a) conversion of syngas or methane into reduction equivalents and at least one of CO2 and formaldehyde, and (b) C1 assimilation via CO2 or formaldehyde, using a CBB cycle, a serine cycle, or a RuMP cycle, wherein the microorganism is genetically modified to express at least one of the enzymatic functions from a recombinant gene.
Most typically, the genetic modification is at least one of (a) a recombinant gene that encodes an enzyme having CO reductase activity, (b) a recombinant gene that encodes an enzyme having hydrogenase activity, (c) a recombinant gene that encodes an enzyme having methane monooxygenase activity, (d) a recombinant gene that encodes an enzyme having alcohol dehydrogenase activity, (e) a recombinant gene that encodes an enzyme having formaldehyde dismutase activity, and (f) a recombinant gene that encodes an enzyme having an activity selected from the group consisting of factor F420-reducing hydrogenase, F420-dependent methylene-H4SPT dehydrogenase, heterodisulfide reductase, methyl-coenzyme M reductase, methyl-H4MPT:coenzyme M methyltransferase complex, F420-dependent methylene-H4SPT reductase, 5,6,7,8-tetrahydromethanopterin hydro-lyase (formaldehyde-activating enzyme), and formaldehyde dehydrogenase.
While not limiting to the inventive subject matter, the microorganism is further modified to have a reduced aldehyde dehydrogenase activity, and will preferably belong to the genus of Ralstonia.
Various objects, features, aspects and advantages of the present invention will become more apparent from the following detailed description of preferred embodiments of the invention.
The inventor discovered that various microorganisms can be genetically modified for microbial synthesis of numerous biofuel components, and especially alcohols, aldehydes, and acids (e.g., keto-acids and hydroxy-acids) from energetic low-molecular weight gases and gas mixtures. In especially preferred aspects, the microorganism is strictly aerobic (e.g., member of the genus Ralstonia) and is in at least some aspects genetically modified to allow for an increased yield of short- and mid-chain alcohols, aldehydes, and carboxylic acids.
For example, particularly preferred processes and microorganisms are those that allow for production of ethanol, C3 alcohols and/or C3 aldehydes, C4-C5 alcohols and/or C4-C5 aldehydes, and/or C6-C8 alcohols and/or C6-C8 aldehydes, or polymeric compounds (e.g., polyhydroxyalkanoates) using syngas or methane as carbon source. Most preferably, the microorganisms are strict aerobic microorganisms, and especially belong to the genus Ralstonia. In other aspects of the inventive subject matter, a microorganism belonging to the genus Ralstonia is genetically modified to allow growth and value product production under anaerobic conditions. Thus, it should be noted that methods and microorganisms according to the inventive subject matter can be used to prepare numerous renewable value-added compounds from (shifted or raw) syngas or methane.
In the simplified schematic of
For example, where methane is used as a carbon feed stock, the methane may first be converted to syngas via steam reformation forming a stream comprising H2 and CO. In some instances, the H2 will be used in the production of other value chemicals or as energy source and as such CO will be available as the feedstock for the microbial conversion of CO to CO2 in which advantageously reduction equivalents are being produced. As used herein, the term “reduction equivalents” refers to molecular entities that are used as cofactors in biological redox processes. Thus, the term “reduction equivalents” especially includes NADH, NADPH, FADH, Ferredoxin, coenzyme F420, and FMNH. For example,
In still further contemplated aspects, and as already noted above, the methane need not necessarily be subjected to a reformation reaction but may also be directly employed as a feedstock. In such case, a microorganism may use (or genetically modified to use) a methane monooxygenase to convert methane to methanol, which may then be further converted via an alcohol oxidase to produce formaldehyde. The so formed formaldehyde may be routed to various other metabolic pathways as further described below, or serve as a substrate for enzymatic conversion to formic acid and further conversion of formic acid to CO2 plus reduction equivalents as exemplarily depicted in
Where maximization of reduction equivalents is particularly desirable, syngas can be used as a feedstock for a microorganism that has or is modified to have a methane oxidation pathway as exemplarily indicated in
In further contemplated aspects of the inventive subject matter, it should be appreciated that the so generated CO2 and reduction equivalents can be used as a carbon source and reductive power to ultimately produce various value products, and especially alcohols, aldehydes, and/or polyhydroxyalkanoates (e.g., polyhydroxybutyric acid, PHB).
More specifically, three molecules of CO2 are channeled through a series of enzymatic reactions that generate a variety of phosphorylated compounds, which when coupled to glycolysis, lead to the formation of a single molecule of pyruvate or acetyl-CoA. In further preferred aspects, the microorganism is genetically modified to express an enzyme activity that utilizes fructose-6-phosphate as a substrate and generates acetylphosphate, a phosphoenolpyruvate precursor, as a product. Enzymes expressing such activity frequently can utilize xylulose-5-phosphate as a substrate and can therefore potentially deplete the CBB cycle of ribulose-5-phosphate utilized in CO2 capture.
The inventor has recently found that this depletion can be avoided by engineering the microorganism to overexpress enzymatic activity that utilizes ribulose-5-phosphate as a substrate to produce ribulose-1,5-diphosphate. This depletes ribulose-5-phosphate, which in turn depletes ribose-5-phosphate, which has the effect of shifting the equilibrium of the reversible transformation between ribose 5-phosphate and xylulose-5-phosphate towards the formation of ribose-5-phosphate. This combination provides an alternate CBB pathway that utilizes the fixation of two molecules of CO2 to produce 1 molecule of acetylCoA, compared to 3 molecules of CO2 via the native CBB cycle, thereby improving the efficiency of CO2 conversion into value-added products otherwise derived from PEP (and/or other 2 carbon metabolites derived from the CBB cycle) at least conceptually from 66% to 100%. Additionally, or alternatively, the inventors also discovered that where cultivation conditions were selected such that the intracellular PEP level is at or below 2 mM (e.g., where nitrogen is present at or below 3 mM in the medium), CO2 fixation and concomitant value product formation is favored. Moreover, the inventor has also noted that the effect of the undesirable xylulose 5-phosphate activity of phosphoketolase can be reduced or even eliminated through overexpression of phosphoribulokinase, an enzyme of the CBB cycle that catalyzes the formation of ribulose 1,5-biphosphate from ribulose 5-phosphate (xylulose-5-phosphate is in equilibrium with ribose 5-phosphate). Overexpression of phosphoribulokinase results in depletion of ribulose 5-phosphate, which in turn leads to depletion of ribose 5-phosphate. This depletion of ribose 5-phosphate shifts the equilibrium between ribose 5-phosphate and xylulose 5-phosphate. This reduces the amount of xylulose 5-phosphate available to act as a substrate for phosphoketolase, effectively reducing this activity (i.e. through substrate competition) while not impacting the production of ribulose 1,5-bisphosphate necessary for CO2 fixation. Such overexpression can reduce the apparent xylulose-5 phosphate activity of a phosphoketolase by 50% or more relative to the activity observed in a similar organism that does not overexpress phosphoribulokinase.
Additionally, it is contemplated that the CBB cycle may be further modified by recombinant expression of phosphoketolase to thereby generate acetylphosphate from an intermediate of the CBB cycle. The so formed acetylphosphate can then be converted in the microorganism acetyl-CoA, that is then used in the cell to produce a value added compound. Further suitable modifications and implications of a modified CBB cycle are described in U.S. 61/933,422, filed 30 Jan. 2014, which is incorporated by reference herein.
In yet further contemplated aspects of the inventive subject matter, it should be noted that microorganisms may also utilize methanol oxidation intermediates for value product production, and especially formaldehyde for C1 fixation to the value products. Of course, it should be appreciated that such fixation capabilities can be native to the microorganism, or due to a genetically engineered metabolic pathway. For example, especially suitable C1 fixation pathways using formaldehyde include the serine cycle and RuMP cycle (ribulose monophosphate cycle). A simplified schematic for the tie-in of methane oxidation with the serine cycle is shown in
More specifically, and with further respect to the serine cycle in
More specifically, and with further reference to
With respect to the microorganism it should be appreciated that the particular nature of the microorganism may change considerably. However, it is generally preferred that the microorganism is a strictly aerobic microorganism. In other aspects, the microorganism may also be a facultative aerobic microorganism, and in some aspects also a facultative anaerobic (or strictly anaerobic) microorganism. Thus, suitable microorganisms will include various bacteria, cyanobacteria, or fungi, and non-photosynthetically active microorganisms are particularly preferred. Therefore, in some embodiments, the microbial cells belong to a genus selected from the group consisting of Escherichia, Corynebacterium, Clostridium, Zymonomas, Salmonella, Rhodococcus, Pseudomonas, Bacillus, Lactobacillus, Enterococcus, Alcaligenes, Klebsiella, Paenibacillus, Arthrobacter, Brevibacterium, Pichia, Candida, Hansenula, Synechococcus, Synechocystis, Anabaena, Ralstonia, Methylobacterium, Methanobacterium, Lactococcus and Saccharomyces.
Therefore, suitable microorganisms may be Escherichia coli, Corynebacterium glutamicum, Clostridium acetobutyricum, Clostridium beijerinckii, Alcaligenes eutrophus, Bacillus subtilis, Bacillus licheniformis, Zymonomas mobilis, Paenibacillus macerans, Rhodococcus erythropolis, Pseudomonas putida, Lactobacillus plantarum, Enterococcus faecium, Enterococcus gallinarium, and Enterococcus faecalis, Synechococcus elongates, Synechocystis sp., Anabaena sp., Ralstonia eutropha, Methylobacterium mesophilicum, Methylobacterium adhaesivum; Methylobacterium aminovorans; Methylobacterium aquaticum; Methylobacterium chloromethanicum; Methylobacterium dichloromethanicum; Methylobacterium extorquens; Methylobacterium fujisawaense; Methylobacterium hispanicum; Methylobacterium isbiliense; Methylobacterium lusitanum; Methylobacterium mesophilicum; Methylobacterium nodulans; Methylobacterium organophilum; Methylobacterium podarium; Methylobacterium populi; Methylobacterium radiotolerans; Methylobacterium rhodesianum; Methylobacterium rhodinum; Methylobacterium suomiense; Methylobacterium thiocyanatum; Methylobacterium variabile; Methylobacterium zatmanii; Methanobacterium bryantii, Methanobacterium formicu, Methanobrevibacter arboriphilicus, Methanobrevibacter gottschalkii, Methanobrevibacter ruminantium, Methanobrevibacter smithii, Methanocalculus chunghsingensis, Methanococcoides burtonii, Methanococcus aeolicus, Methanococcus deltae, Methanococcus jannaschii, Methanococcus maripaludis, Methanococcus vannielii, Methanocorpusculum labreanum, Methanoculleus bourgensis, Methanoculleus marisnigri, Methanofollis liminatans, Methanogenium cariaci, Methanogenium frigidum, Methanogenium organophilum, Methanogenium wolfei, Methanomicrobium mobile, Methanopyrus kandleri, Methanoregula boonei, Methanosaeta concilii, Methanosaeta thermophile, Methanosarcina acetivorans, Methanosarcina barkeri, Methanosarcina mazei, Methanosphaera stadtmanae, Methanospirillium hungatei, Methanothermobacter defluvii, Methanothermobacter thermautotrophicus, Methanothermobacter thermoflexus, Methanothermobacter wolfei, Methanothrix sochngenii, Lactococcus lactis and Saccharomyces cerevisiae.
It should further be appreciated that the microorganism contemplated herein will generally be capable of using a gaseous substrate as carbon source without genetic modification, but may also be engineered to impart capability of using or to use a specific gaseous substrate (and especially methane, syngas, or a mixture of CO2:CO:H2 at any ratio). For example, engineered microorganisms contemplated herein will be able to convert methane to formaldehyde and gain reduced NAD(P)H through this process, wherein (a) the formaldehyde can be fixed directly or (b) can be converted to CO2 and NAD(P)H. In another example, the engineered microorganism may also be capable of converting syngas or a CO2:CO:H2 mixture to CO2 and NAD(P)H, and fix CO2.
Therefore, especially preferred microorganisms will comprise (naturally or via genetic engineering) one or more enzymes suitable for one or more of the following pathways: pyruvate to acetaldehyde by pyruvate decarboxylase; 2-ketobutyrate to propanal by 2-ketoisovalerate decarboxylase; linear carbon chain elongation using leuABCD genes; decarboxylation of one or more of 2-ketovalerate, 2-ketocaproate, 2-ketoheptanoate, 2-ketooctanoate, 2-keto-3-methylvalerate, 2-keto-4-methylcaproate, 2-keto-5-methylheptanoate, 2-keto-6-methyloctanoate, 2-keto-isovalerate, 2-ketoisocaproate, 2-keto-5-methylhexanoate, or 2-keto-6-methylocatnoate by kivd; branched carbon chain elongation of 2-ketobutyrate to 2-keto-3-methylvalerate using ilvGMCD or ilvBNCD; and branched carbon chain elongation of pyruvate to 2-keto-isovalerate using alsS and ilvCD or ilvIHCD genes.
Viewed from another perspective, the microorganisms comprise one or more native or recombinant active enzymes from one or more of the following pathways: methane to methyl-CoM; methyl-CoM to 5-methyl-THMPT; 5-methyl-THMPT to 5,10-methyl-THMPT; 5,10-methyl-THMPT to Formaldehyde; methane to methanol; methanol to formaldehyde; formaldehyde to formic acid; formic acid to carbon dioxide; carbon monoxide to carbon dioxide; hydrogen and oxidized NAD(P)+ to reduced NAD(P)H and proton. Consequently, and viewed from a different perspective, contemplated microorganisms may also have a native and/or recombinant active enzyme selected from the group consisting of an acetyl-CoA acetyltransferase, an 3-hydroxyacyl-CoA dehydrogenase, a crotonyl-CoA hydratase, a butyryl-CoA dehydrogenase, a trans-enoyl-CoA reductase and a butanal dehydrogenase.
In certain cases, the microorganism will also have a reduced activity of one or more enzymes capable of modifying the specific chemical produced, and most typically a reduced or eliminated activity for alcohol and/or aldehydes (other than formaldehyde) dehydrogenase activity. Thus, contemplated microorganisms may have (naturally or via genetic modification) reduced activity of one or more native alcohol dehydrogenases to block the conversion of specific C3-C8 aldehyde into corresponding C3-C8 alcohols compared to unmodified microorganism. Therefore, preferred products include alcohols such as ethanol, 1-propanol, 1-butanol, isobutanol, 1-pentanol, 1-hexanol, 1-heptanol, 1-octanol, 2-metyl-1-propanol, 3-methyl-1-butanol, 4-methyl-1-pentanol, 2-methyl-1-butanol, 3-methyl-1-pentanol, and 4-methyl-1-hexanol. Likewise, preferred products include aldehydes such as acetaldehyde, 1-propanal, 1-butanal, 1-pentanal, 1-hexanal, 1-hexanal, 1-heptanal, 1-octanal, 2-metyl-1-propanal, 3-methyl-1-butanal, 4-methyl-1-pentanal, 2-methyl-1-butanal, 3-methyl-1-pentanal, and 4-methyl-1-hexanal; and carboxylic acids (which may also be keto- or hydroxy acids) such as acetate, lactate, n-butyric acid, isobutyric acid.
With further respect to reduced activities of particular enzymes (and especially alcohol dehydrogenases), it is generally preferred that the activity is reduced via deletion, knock-down, or knock-out mutations (e.g., via antisense RNA or siRNA, gene disruption, etc.). For example, expression (transcription and/or translation) of one or more endogenous alcohol dehydrogenase activity will be at least decreased, and more preferably suppressed, and it should be noted that in especially preferred aspects, all or almost all of the alcohol dehydrogenases will be suppressed or deleted. For example, suppressed or deleted dehydrogenases include adhE, IdhA, frdB, and pflB. Likewise, it is contemplated that one or more aldehyde dehydrogenases (other than formaldehyde dehydrogenase) will be deleted, especially where the desired value product is an C2+ aldehyde.
Of course, it should be recognized that all of the genes encoding the desired enzymatic activity may be unmodified or may be engineered to impart a desired selectivity, an increased turnover rate, etc. (see e.g., Proc. Nat. Acad. Sci. (2008), 105, no. 52: 20653-20658; or WO2009/149240A1). Suitable genes for the above and further activities of the metabolically engineered cells are well known in the art, and use of all of those in conjunction with the teachings presented herein is deemed suitable. Moreover, all of the known manners of making metabolically engineered cells are deemed suitable for use herein. For example, metabolically engineered cells may modified by genomic insertion of one or more genes, operons, and/or transfection with plasmids or phagemids as is well known in the art. In some embodiments, a mutant microorganism may also be used in the methods of the present invention, and may be further modified recombinantly as desired.
Viewed from a different perspective, recombinant microorganism may be prepared using all methods known to one of ordinary skill in the art, and it will be understood that modifications may include insertion or deletion of one or more genes as deemed necessary to increase or decrease activity of a particular enzymatic pathway. Thus, suitable modifications will include random mutagenesis to produce deficient expression patterns, extrachromosomal (typically plasmids or phagemid) nucleic acids with suitable control elements to produce controlled overexpression of one or more enzymes, genomic insertions with suitable control elements to produce controlled overexpression of one or more enzymes, etc.
For example, suitable energetic low-molecular weight gas include raw or processed or purified syngas streams from gasification operations, which may or may not have undergone a shift reaction, recycle gas streams in gas processing operations (and especially gasification operations), off gases or purge gases from pressure swing adsorption units, catalytic and non-catalytic hydrogenation operations, hydrocracking operations, etc., all of which may be combined with CO and CO2 rich gas streams that may be derived from numerous sources, including combustion units, coking units, catalyst regenerators, etc. Moreover, suitable energetic low-molecular weight gas may also be derived from landfill operations, gasification and reliquefaction operations, natural gas receiving and processing terminals, etc. Still further, contemplated energetic low-molecular weight gas may also be obtained from solid or liquid adsorbent compositions as well as cryogenic operations.
Therefore, and viewed from a different perspective, suitable energetic low-molecular weight gases will comprise CO, CO2, and/or CH4 in an amount of at least 2-5 vol %, more typically between 5-10 vol %, even more typically between 10-30 vol %, and most typically between 30-50 vol % and even more. Likewise, the hydrogen concentration may vary considerably and will generally be at least 0.5-5 vol %, more typically between 5-10 vol %, even more typically between 10-30 vol %, and most typically between 30-50 vol % and even more. In addition, suitable media will also include additional non-gaseous carbon sources as desired. For example, appropriate additional carbon sources include various saccharides, and particularly glucose, fructose, sucrose, starch, cellulose, hemicellulose, glycerol, carbon dioxide, protein and fragments thereof, and/or amino acids. Exemplary further carbon sources include lipids, proteins, complex organic mixtures (e.g., biosolids, meat processing waste products, plant based materials, etc).
The flow rate of the energetic low-molecular weight gas will typically be well above the rate required to obtain saturation of the energetic low-molecular weight gas in the medium. Thus, suitable flow rates will result in bubble formation in the medium, which may be vigorous enough to drive of volatile reaction products from the microorganism. Therefore, in especially preferred aspects of the inventive subject matter, preferred flow rates will be between 0.5-1.0 vvm, more typically between 1.0-1.5 vvm, and even more typically between 1.5-3.0 vvm.
It should further be appreciated that the culture conditions will typically depend on the particular choice of microorganism, and the person of ordinary skill in the art will be readily able to choose the appropriate medium. Among other suitable choices, it is generally preferred that the carbon source in the medium is provided to at least some degree (e.g., at least 30%, more typically at least 50%, most typically at least 75%), and more typically substantially entirely (e.g., at least 90%, more typically at least 90%, most typically at least 95%) provided in gaseous form from an energetic low-molecular weight gas. Most preferably, the energetic low-molecular weight gas is or comprises methane, ethane, syngas, or modifications thereof, or any gas that provides a net exothermic reaction when combusted with oxygen and in which the largest volatile component has a molecular weight of less than 100 Da. Moreover, it is noted that in at least some aspects of the inventive subject matter the microorganism is grown and used to produce value product under aerobic conditions, which is typically not advised due to the nature of the energetic gases. However, it should be appreciated that the gas composition may be controlled such that aerobic growth is promoted while reducing or avoiding conditions that favor autoignition or explosion.
Regardless of the particular culture condition, it is especially preferred that the reaction products produced by the microorganism are removed in the gas phase where the reaction product is a volatile compound (e.g., butyraldehyde). More preferably, such removal will be performed in a continuous fashion during cell culture, and removal may be based on agitation of the fermentation medium, stripping the fermentation medium with an inert gas, stripping the fermentation medium with an oxygen containing gas, and/or temporarily binding the aldehyde to a binding agent. For example, suitable gases used in the gas stripping process may be methane, syngas, air, nitrogen, ammonia, carbon dioxide, carbon monoxide, hydrogen, oxygen, and all reasonable combinations thereof combinations thereof. Alternatively, aldehyde removal may also be performed after fermentation, or in a semi-continuous manner (e.g., by intermittent contact with stripping gas). Once driven off the fermentation medium, various methods may be used to recover the reaction product, including trapping in solution, by dissolution or adsorption into solvent, or via adsorption onto a solid sorbent. The so recovered product may then be sold as a commodity or converted to a desirable product via oxidation, reduction, or condensation.
Alternatively, and especially where the reaction product is not sufficiently volatile to be removed in meaningful quantities from the medium, the reaction product may be removed from the liquid phase. Thus, and depending on the production kinetics, removal may be performed on-line from a continuous fermentation, or intermittently from batch fermentation. Among other suitable removal methods, preferred methods include distillation, differential solubilization in solvents immiscible with the culture medium, adsorption using specific or non-specific solvents, etc. Consequently, it should also be appreciated that the type of fermentation system may vary considerably, and appropriate fermentation systems include batch fermentors, continuous fermentors, and fermentors with a solid phase (e.g., hollow-fiber reactors, etc.) that retain the microorganisms.
For example, in one especially preferred aspect of the inventive subject matter, the microorganism is Ralstonia eutropha and is cultured in an appropriate liquid medium using syngas having a molar ratio of H2 to CO of about 3 to 1 at a feed rate of about 1.5-2.5 vvm under aerobic culture conditions. Most typically, the syngas is a raw syngas from a steam hydrogasification and/or steam reforming operation in which biomass is converted to the syngas. Thus, the syngas will also include further non-energetic and inert components. In particularly preferred embodiments, the feed gas is not only used to provide a carbon source and hydrogen to the microorganism, but is also used at a rate effective to sparge out desired products from the liquid phase in which the microorganisms grow. Alternatively, or additionally, desired products can also be extracted from the liquid phase.
Consequently, it should be appreciated that using contemplated systems and methods one can use industrial byproducts (e.g., CO2 or methane) as raw material to produce value-added products. Most typically, CO2 and methane can be converted to formic acid or formaldehyde, and Ralstonia eutropha (or other suitable microorganism) can be used to convert formic acid or formaldehyde to polymers, bulk chemicals and pharmaceutical intermediates. It should be particularly noted that such process does generally not rely on the relatively slow photosynthetic process to fix CO2, and therefore has a much higher CO2 fixation rate compared with all plant- or algae-based CO2 fixation processes. Current biomass productions by plants or algae require a large area of agricultural land, moderate temperature and constant light distribution. Contemplated processes exploit Ralstonia's CO2 fixation rate (0.4 g/L/day according to Ishizaki et al., 2001, equivalent to 400 g/m2/day in a 1 m high bioreactor), which is significantly higher than plant- or algae-based CO2 fixation processes (2 g/m2/day and 50 g/m2/day, respectively), which rely on the slow process of photosynthesis (Zhu et al., 2008). Using a continuous fermentation, a metabolically engineered Ralstonia could produce 2 g/L/day biomass in which 30% of the dry weight is PHA and 50% of the dry weight is protein. Since there is little chance that any other microorganism could grow in formic acid, there is no concern of contamination which is a common problem for other fermentation industries. When an open pond or closed bioreactor is used, a metabolically engineered Ralstonia could fix over 400 g/m2/day CO2 assuming the depth of the open pond is 1 m, or could fix over 4000 g/m2/day CO2 assuming the depth of a bioreactor is 10 m.
Further considerations, methods, and compositions suitable for use herein are described in U.S. Pat. No. 7,851,188 and in International applications with the serial numbers PCT/US12/29013 (published as WO2012/125688) and PCT/US12/63288 (not yet published), all of which are incorporated by reference herein.
Thus, specific embodiments and applications of methods of microbial production of fuel components from low-molecular weight gas mixtures have been disclosed. It should be apparent, however, to those skilled in the art that many more modifications besides those already described are possible without departing from the inventive concepts herein. The inventive subject matter, therefore, is not to be restricted except in the spirit of the appended claims.
This application is a divisional of U.S. application Ser. No. 15/336,744, filed Oct. 27, 2016, which is a divisional of U.S. application Ser. No. 14/187,465, filed Feb. 24, 2014, now U.S. Pat. No. 9,512,450, which claims priority to U.S. provisional application Ser. No. 61/768,152, filed Feb. 22, 2013, all of which are incorporated by reference herein.
Entry |
---|
Anne M Henstra et al Microbiology of synthesis gas fermentation for biofuel production Current Opinion in Biotechnology 2007, 18: 200-206 (Year: 2007). |
Hanson et al (Methanotrophic Bacteria, Microbiological Reviews, Jun. 1996, p. 439-471,(American Society for Microbiology). |
Xin, et al., Production of Methanol from Methane by Methanotrophic Bacteria Biocatalysis and Biotransformation, 2004 vol. 22 (3). pp. 225 229. |
Hollaender et al (Genetic Engineering of Microorganisms for Chemicals, 383-402, 1982). |
Number | Date | Country | |
---|---|---|---|
20190040421 A1 | Feb 2019 | US |
Number | Date | Country | |
---|---|---|---|
61768152 | Feb 2013 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15336744 | Oct 2016 | US |
Child | 16157299 | US | |
Parent | 14187465 | Feb 2014 | US |
Child | 15336744 | US |